Премини към съдържанието
HPB-ALL
Тъкан
Peripheral blood
Заболяване
Precursor T-cell acute lymphoblastic leukemia
Място на метастазите
Peripheral blood (systemic T-ALL)
Синоними
HPB/ALL, HPBALL, FCCH1018

Документи

HPB-ALL

Cell line · Номер на продукта 302895

HPB-ALL е клетъчна линия на остра лимфобластна левкемия от Т-клетки (T-ALL) при човека, получена от периферната кръв на 14-годишен японски мъж...

€430.00без ДДС и доставка

Персонализиране / Препоръки

На склад
Лот
Препоръчани (най-новата партида)
  • CoA
1

01Обща информация

Описание

HPB-ALL is a human precursor T-cell acute lymphoblastic leukemia (T-ALL) cell line established from the peripheral blood of a 14-year-old Japanese male patient. The line grows in suspension with lymphocyte-like morphology. HPB-ALL harbors a complex TP53 mutational profile with eight mutations across heterozygous and homozygous states, reflecting the genetic complexity of T-ALL at diagnosis. The line expresses T cell surface markers consistent with T-ALL biology, making it relevant for studies of T lymphoblast leukemia pathogenesis and drug responses.

HPB-ALL is applicable in studies of T-ALL biology, TP53 multi-mutant phenotype, anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine), Notch and JAK-STAT pathway analysis, and comparative studies within the T-ALL cell line panel. It is suitable for in vitro pharmacological assays and xenograft models in immunocompromised hosts for preclinical T-ALL drug evaluation. Doubling time approximately 50 hours.

Тъкан
Peripheral blood
Заболяване
Precursor T-cell acute lymphoblastic leukemia
Място на метастазите
Peripheral blood (systemic T-ALL)
Приложения
T-ALL biology; TP53 multi-mutant phenotype; anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine); Notch/JAK-STAT pathways; xenograft models; T-ALL panel comparative studies
Синоними
  • HPB/ALL
  • HPBALL
  • FCCH1018

02Класификация

Организъм
Човек
Секс
Мъж
Свойства, свързани с растежа
Окачване
Ниво на биологична безопасност
1

03Характеристики

Морфология
Lymphoblast-like
Тип клетка
T-cell
Време за удвояване
~50 hours

04Идентификатори

Източник
HPB-ALL (Cytion catalog number 302895)
Данъчен идентификационен номер в NCBI
9606
Целозавър
CVCL_1820

05Проява и предразположеност

Мутационен профил
Mutation: p.Arg465His, Unspecified; Mutation: p.Ala134Ser, Unspecified; Mutation: p.Leu1574Pro, Heterozygous; Mutation: p.Asp2442fs*39, Heterozygous; Mutation: p.Arg159Ser, Unspecified; Mutation: p.Cys124Ter, Homozygous; Mutation: p.Arg273Cys, Unspecified; Mutation: p.Ser121Ter, Unspecified

06Обработка и отглеждане

Хранителна среда
RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Добавки
Supplement the medium with 10% FBS
Реагент за дисоциация
dilution
Пресаждане
Dilute the culture to 2–5 × 10⁵ cells/ml with fresh pre-warmed complete medium twice per week. No enzymatic dissociation required.
Коефициент на разделяне
1 : 10 split
Плътност на засяването
3-5*10^5/ml
Обновяване на течността
Subculture : 2 times/week
Размразяване и култивиране
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 200 x g for 5 minutes, carefully discard the supernatant containing freezing medium.

  7. Follow the procedure described under Post-Thaw Recovery

07Контрол на качеството и криоконсервация

Среда за замразяване
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Условия за съхранение

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Условия за доставка

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Дарител

Възраст на донора
14 years
Етническа принадлежност
Japanese

10Подробности за продукта

Таблица със състава